Showing 141 - 160 results of 1,866 for search '"spondylitis"', query time: 0.09s Refine Results
  1. 141
  2. 142
  3. 143

    Functional characterization of ankylosing spondylitis genetic risk variants by Osgood, JA

    Published 2019
    “…<p>Ankylosing spondylitis (AS) is a chronic inflammatory arthritis characterized by inflammation and osteoproliferation in the lower spine and sacroiliac joints. …”
    Thesis
  4. 144

    Non-B27 MHC associations of ankylosing spondylitis. by Sims, A, Barnardo, M, Herzberg, I, Bradbury, L, Calin, A, Wordsworth, B, Darke, C, Brown, M

    Published 2007
    “…Ankylosing spondylitis (AS) has been associated with human leukocyte antigen (HLA)-B27 for over 30 years; however, the mechanism of action has remained elusive. …”
    Journal article
  5. 145
  6. 146
  7. 147
  8. 148

    INVESTIGATION OF A ROLE OF THE IMMUNOGENICITY OF INFLIXIMAB IN THE THERAPY OF ANKYLOSING SPONDYLITIS by O. A. Rumyantseva, A. G. Bochkova, M. M. Urumova, M. V. Cherkasova, E. N. Aleksandrova, S. K. Solovyev, Sh. F. Erdes

    Published 2016-09-01
    “…At present, there are a number of unsolved problems associated with unawareness of the causes and ways to prevent the inefficacy of tumor necrosis factor-α  inhibitors.Objective: to study the causes of secondary inefficacy of infliximab (INF), by analyzing its concentrations and antidrug antibody levels in the serum of ankylosing spondylitis (AS) patients receiving long INF,  as well as a possibility to overcome its secondary inefficacy through plasmapheresis.Subjects and methods. 54 patients with active AS (BASDAI &gt; 4) underwent regular long-term  (1-to-10-year) treatment with INF 5 mg/kg according to the standard scheme. …”
    Get full text
    Article
  9. 149
  10. 150
  11. 151

    THE POSSIBILITIES AND RESULTS OF INDIRECT COMPARISON OF BIOLOGICAL AGENTS IN ANKYLOSING SPONDYLITIS by Sh. F. Erdes

    Published 2016-12-01
    “…The paper analyzes two matching-adjusted indirect comparison-based investigations of the efficacy of adalimumab (ADA) and secukinumab (SCM) in active ankylosing spondylitis, which have been recently reported at the EULAR Congress (London, 2016). …”
    Get full text
    Article
  12. 152
  13. 153
  14. 154
  15. 155

    A Case Report on the Rare Presentation of Brucellosis-induced Spondylitis by Nivetha Manivannan Raj, Priya Periaiah, Senita Samuel, Vengadakrishnan Krishnamoorthy

    Published 2024-03-01
    “…Arthritis (most common), bursitis, tenosynovitis, sacroiliitis, spondylitis, and osteomyelitis are among the range of bone and joint disorders. …”
    Get full text
    Article
  16. 156
  17. 157

    Lipoma Arborescens of Hip Joint in a Case of Ankylosing Spondylitis by Nikita Jindal, Ranjana Gupta, Puneet Mittal, Venkata Raviteja Reddy Gayam, Sanjay Singh

    Published 2022-04-01
    “…Here the authors present a case of a 35-year-old female patient who presented with active bilateral sarcroiliitis who was a known case of Human Leukocyte Antigen B27 (HLA-B27) positive ankylosing spondylitis for the past four years. The Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) findings suggestive of Lipoma arborescens of the hip joint in association with ankylosing spondylitis is reported.…”
    Get full text
    Article
  18. 158

    Splenic tuberculosis in a patient with ankylosing spondylitis treated with adalimumab by M. Fernandes, A.M. Ferreira, A. Ferreira, T. Tosin, E. Paiva, V.F. Azevedo

    Published 2011-11-01
    Subjects: “…Splenic tuberculosis, ankylosing spondylitis, anti- TNF therapy…”
    Get full text
    Article
  19. 159

    EXPERIENCE OF TREATMENT OF JUVENILE ANKYLOSING SPONDYLITIS WITH EYES LESION WITH ADALIMUMAB by E.I. Alexeeva, S.I. Valieva, T.M. Bzarova, A.O. Lisitsin, N.A. Karagulyan

    Published 2009-01-01
    “…This article presents a case report of juvenile ankylosing spondylitis and severe uveitis. A successful treatment with biological agent adalimumab was described. …”
    Get full text
    Article
  20. 160